Ep 39: Dr. Amy Abernethy on the Future of Real-World Evidence and Regulating Generative AI

This podcast episode explores the evolution of real-world evidence (RWE) and its increasing acceptance by regulators. It highlights the impact of the COVID-19 pandemic on the use of RWE and the lessons learned regarding data controls and peer review. The episode discusses the future of clinical research, emphasizing the importance of multi-use data, metadata permissions, and controls. It also delves into key considerations for healthcare startups, including data permissions, AI applications, and regulatory engagement. The episode concludes with a look at the journey of Verily and the reasons behind Amy Abernethy's pursuit of her work in the nonprofit space.